Foley Partner Antoinette Konski authored an article that appeared in the September 2011 issue of BioProcess International titled “Generic Biologics.” Konski reviews several key provisions of various regulatory pathways for generic biologics in the United States, China, India and throughout Europe, and discusses how these pathways could support biosimilar manufacturing.
Click here to read the complete article.
Author(s)
Related Insights
May 20, 2026
Manufacturing Industry Advisor
Agentic AI Liability in Autonomous Supply Chain Decisions: Identifying and Preventing Legal Risks
By 2026, “digital twins” and AI‑driven predictive analytics have become essential tools in supply chain and industrial manufacturing. Specifically, the digital twin in manufacturing represents a paradigm shift in how organizations manage production planning, supplier selection, capacity forecasting, inventory optimization, and quality control across global supply chains. For example, General Motors announced in March 2025 that it was working with NVIDIA Omniverse to create digital twins of assembly lines, and in March 2026 Delta Electronics announced a similar plan to monitor factory HVAC, lighting, and energy savings. As adoption accelerates, organizations should understand both the strategic advantages and the legal issues these technologies present.
May 20, 2026
The Path & The Practice
Episode 137: René Jovel
This episode features a conversation with René Jovel, Assistant General Counsel at Versiti Blood Health, Inc. In this discussion, René reflects on growing up in Los Angeles, California, attending Northwestern University for undergrad and Marquette University School of Law.
May 20, 2026
Foley Ignite
AI, Automation, and Robotics Are Reshaping Value Creation for Private Equity
What I am seeing in deal rooms across Silicon Valley and the rest of the state is that sponsors have stopped opening with the old questions. The first question I get now is some version of, where does AI live inside this business, and what is it worth if we get it right?